Evolent Health, Inc (EVH) financial statements (2021 and earlier)

Company profile

Business Address 800 NORTH GLEBE RD, SUITE 500
ARLINGTON, VA 22203
State of Incorp. DE
Fiscal Year End December 31
SIC 8741 - Management Services (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments103228238179155
Cash and cash equivalents101228238135146
Short-term investments2  449
Restricted cash and investments2015562345
Receivables7278755120
Contract with customer, asset22✕✕✕
Other undisclosed current assets3224314
Total current assets:229488378265184
Noncurrent Assets
Operating lease, right-of-use asset72✕✕✕✕
Property, plant and equipment8574513113
Long-term investments and receivables140132245
Long-term investments13962245
Accounts and financing receivable, after allowance for credit loss17   
Intangible assets, net (including goodwill)8811,103869885772
Goodwill572768628627609
Intangible assets, net (excluding goodwill)308335241259163
Contract with customer, asset, net11✕✕✕
Capitalized contract cost, net3619✕✕✕
Restricted cash and investments86362
Other undisclosed noncurrent assets4618910 
Total noncurrent assets:1,2691,234935935831
TOTAL ASSETS:1,4981,7221,3131,2001,016
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10622110811145
Accounts payable37147434417
Accrued liabilities334930296
Employee-related liabilities3525353822
Deferred revenue20✕✕✕✕
Debt6    
Due to related parties 1   
Deferred revenue and credits✕✕252015
Contract with customer, liability✕21✕✕✕
Other undisclosed current liabilities6127   
Total current liabilities:19326913313260
Noncurrent Liabilities
Long-term debt and lease obligation69    
Operating lease, liability69✕✕✕✕
Liabilities, other than long-term debt1519123621
Deferred revenue1✕✕✕✕
Contract with customer, liability✕2✕✕✕
Deferred tax liabilities, net✕ 22121
Deferred income tax liabilities2✕✕✕✕
Other liabilities121710150
Other undisclosed noncurrent liabilities292245121120 
Total noncurrent liabilities:37626413415621
Total liabilities:56953326628881
Stockholders' equity
Stockholders' equity attributable to parent, including:9221,1441,011703649
Additional paid in capital1,1741,093924555342
Accumulated other comprehensive loss(0)(0)   
Retained earnings (accumulated deficit)(252)5086147307
Other undisclosed stockholders' equity attributable to parent11111
Stockholders' equity attributable to noncontrolling interest74635210285
Total stockholders' equity:9291,1891,046912935
TOTAL LIABILITIES AND EQUITY:1,4981,7221,3131,2001,016

Income statement (P&L) ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues84662743525497
Revenue, net✕✕43525497
Cost of revenue
(Policyholder Benefits and Claims Incurred, Net)		 (1)   
Gross profit:84662643525497
Operating expenses(1,153)(675)(508)(492)(140)
Other undisclosed operating income 1   
Operating loss:(307)(47)(73)(237)(43)
Nonoperating income342 414
Investment income, nonoperating432 414
Interest and debt expense(15)(5)(4)  
Income (loss) from continuing operations before equity method investments, income taxes:(318)(49)(75)(237)371
Loss from equity method investments(9)(5)(2)(1)(28)
Other undisclosed income from continuing operations before income taxes  010
Income (loss) from continuing operations before income taxes:(327)(54)(76)(238)343
Income tax expense (benefit)22(0)711(23)
Net income (loss):(306)(54)(70)(227)320
Net income attributable to noncontrolling interest4296713
Net income (loss) attributable to parent:(302)(53)(61)(160)332
Preferred stock dividends and other adjustments    (2)
Net income (loss) available to common stockholders, basic:(302)(53)(61)(160)330
Convertible preferred dividends    2
Other undisclosed net loss available to common stockholders, diluted    (13)
Net income (loss) available to common stockholders, diluted:(302)(53)(61)(160)320

Comprehensive Income ($ in millions)
Annual | Quarterly

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(306)(54)(70)(227)320
Other undisclosed comprehensive loss(0)(0)   
Comprehensive income (loss):(306)(54)(70)(227)320
Comprehensive income, net of tax, attributable to noncontrolling interest4296713
Comprehensive income (loss), net of tax, attributable to parent:(302)(53)(61)(160)332

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: